Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 160 participants.

Also called NCT06078436

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Min-Seok Kim (from the registry)
Registry
  • NCT NCT06078436
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06078436. Randomized; no masking; primary purpose treatment. Start 2024-01 (anticipated); primary completion 2027-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF
Acronym
PACE-SHOCK
Condition
Cardiogenic Shock
Intervention (Device)
Pulmonary artery catheter
Lead sponsor
Min-Seok Kim (class: other)

Record details

Record id
cardio:ct-nct06078436
Content hash
2124617bc320e742c3988413efbf3545e1c9924b669c41442a11057424b6075d